Ku Leighton, Bruen Brian K, Steinmetz Erika, Bysshe Tyler
Leighton Ku (
Brian K. Bruen is a lead research scientist and lecturer in the Department of Health Policy and Management at the George Washington University.
Health Aff (Millwood). 2016 Jan;35(1):62-70. doi: 10.1377/hlthaff.2015.0756.
Medicaid enrollees are about twice as likely as the general US population to smoke tobacco: 32 percent of people in the program identify themselves as smokers. This article provides the first data about the effectiveness of state Medicaid programs in promoting smoking cessation. Our analysis of Medicaid enrollees' use of cessation medications found that about 10 percent of current smokers received cessation medications in 2013. Every state Medicaid program covers cessation benefits, but the use of these medications varies widely, with the rate in Minnesota being thirty times higher than that in Texas. Most states could increase their efforts to help smokers quit, working with public health agencies, managed care plans, and others. In 2013 Medicaid spent $103 million on cessation medications-less than 0.25 percent of the estimated cost to Medicaid of smoking-related diseases. Additionally, states that have not expanded Medicaid eligibility in the wake of the Affordable Care Act have higher smoking prevalence and lower utilization rates of cessation medication, compared to expansion states. Given these factors, nonexpansion states will have a greater public health burden related to smoking. Medicaid and public health agencies should work together to make smoking cessation a priority for Medicaid beneficiaries.
该计划中32%的人认为自己是吸烟者。本文首次提供了关于各州医疗补助计划在促进戒烟方面有效性的数据。我们对医疗补助计划参保者使用戒烟药物的分析发现,2013年约10%的当前吸烟者接受了戒烟药物治疗。每个州的医疗补助计划都涵盖戒烟福利,但这些药物的使用差异很大,明尼苏达州的使用率比得克萨斯州高30倍。大多数州可以加大力度帮助吸烟者戒烟,与公共卫生机构、管理式医疗计划及其他机构合作。2013年,医疗补助计划在戒烟药物上花费了1.03亿美元,不到与吸烟相关疾病给医疗补助计划造成的估计成本的0.25%。此外,与扩大医保资格的州相比,在《平价医疗法案》出台后未扩大医疗补助资格的州吸烟率更高,戒烟药物利用率更低。鉴于这些因素,未扩大医保资格的州将面临与吸烟相关的更大公共卫生负担。医疗补助计划和公共卫生机构应共同努力,将帮助医疗补助受益者戒烟作为优先事项。